This is an automated archive made by the Lemmit Bot.
The original was posted on /r/ufos by /u/VolarRecords on 2024-11-20 10:19:32+00:00.
Original Title: The Sol Foundation and their new White Paper - The Prospect of Executive Branch Unidentified Anomalous Phenomena Secrecy: The Harm to Congress and Potential Remedies - Peter Skafish - Vol. 1 No. 6 - November 2024
With so much happening so fast in this subject and the world at large, it's understandable that most of us have a difficult time stepping back and taking in the bird's-eye view of our present moment of our new UFO/UAP reality.
I initially started this post to help break down some of the new White Paper by Sol Foundation published in the last week or so. I'll include as much of that below as possible. Of course, digest the whole thing on your own accord.
The Prospect of Executive Branch Unidentified Anomalous Phenomena Secrecy: The Harm to Congress and Potential Remedies: Peter Skafish -- Vol. 1 No. 6 -- November 2024
You can read the first five White Papers here:
https://thesolfoundation.org/white-papers/
But before that, I thought it would be a good chance to remind folks of who the Sol Foundation are.
The Sol Foundation was formed by Garry Nolan, Peter Skafish, David Grusch, and others, in tandem with the revelations of Grusch revealing a decades-long UFO/UAP crash-retrieval reverse-engineering program via an interview with Ross Coulthart for NewsNation that led to an immediate hearing in Congress.
That Congressional hearing can be seen here:
Here's Coulthart breaking down the story behind getting Grusch to come forward:
Here's Coulthart talking about Grusch and whistleblowers on Curt Jaimungal's Theory of Everything podcast/channel:
Here's Lue Elizondo two months ago on Coulthart's Reality Check with Marik von Rennenkampff, opinion contributor for The Hill and former analyst at the State and Defense departments, talking about how Grusch is a "hero" for coming forward:
Here's some basic info about the Sol Foundation:
Confirmation that genuine Unidentified Aerial Phenomena exist would be world-changing in every sense of the term. The Sol Foundation marshals intellectual insight and policy expertise to meet the scientific and political challenges.
Introducing the Sol Foundation
Science, Policy, and Public Education for a Post-UAP World
Why a UAP-Focused Foundation and Center of Research?
The time has come for serious, well-funded, and cutting-edge academic research into the nature of Unidentified Aerial Phenomena and their broad cosmological and political implications. Such a claim would have been beyond the pale of respectability just five years ago, but the U.S. government’s recent and continued acknowledgments of UAP have changed them from a subject unworthy of academic consideration into a scientific and intellectual problem of unfathomably broad stakes. Now that UAP are considered real enough by Congress to be addressed with federal legislation, we are forced to consider the broad consequences of this for the future of science, technology, economy, politics, law, religion, culture, and all other human institutions and endeavors.
The Sol Foundation is accordingly establishing itself as a premier center for UAP research. Under the direction of academic and government experts already professionally engaged in the study of UAP, the Foundation is assembling teams of noted specialists in the natural sciences, the social sciences, the humanities, and engineering, information science, and other technology-focused disciplines. Collectively, these teams will undertake rigorous, methodical, and cutting-edge inquiry into UAP and their implications as well as help set the agenda for UAP Studies.
Sol’s Work and Mission
As revelation of the reality of UAP would be world-changing in every sense of the term, the Foundation’s work is not confined to purely academic research but extends to advisory and policy work as well as public education. In sum, the Sol Foundation’s mission is threefold:
To help fund and set a clear direction for the initial 25 years of public research related to UAP, nonhuman intelligences, and the implications of their existence for human understandings of nature, society, technology, and politics. In this, the Foundation intends to be the leading source of the best scientific, intellectual, and policy research on the issue.
To provide reliable, cutting-edge advisory research to the United States’ and other national governments as well as corporate clients. Sol will establish itself as and remain the foremost think tank on UAP: the source of the most informed and insightful policy recommendations available.
To offer insight and guidance to the public on the cosmological and political implications of UAP. As humanity grows to understand that it is not the sole intelligence in the universe, Sol will share its perspectives on how humans might creatively respond to this new reality.
Social Responsibility, Democracy, and Humanity
As government engagements with UAP are freighted by a history of secrecy and overclassification, Sol is committed to developing a socially responsible approach to the issue—one appropriate for democratic societies. In this regard, we have three aims:
The establishment and maintenance by the United States’ and other national governments of informed, democratic oversight of their UAP engagements, including by creating public transparency.
The promotion of UAP-related research that is commercially and ecologically responsible.
The fostering of a greater sense of common humanity across cultures, faiths, nations, and polities, including by supporting the development of UAP-focused initiatives at international institutions.
Grusch, along with Garry Nolan, Peter Skafish, and others, formed the 501c3 non-profit Sol Foundation to explore and disseminate the reality of UFOs/UAP and the Phenomena at large. Included in the board for this non-profit are Charles "Chuck" McCullough, legal counsel for Grusch and the Sol Foundation; Jonathan Berte, Board of Directors, European Union and Technology and Investment Advisory Boards; and Maura Mindrila, Director of Strategy.
Here are their breakdowns below:
Garry Nolan
Executive Director of the Board
Dr. Nolan is the Rachford and Carlota A. Harris Professor in the Department of Pathology at Stanford University School of Medicine. He trained with Leonard Herzenberg (for his Ph.D.) and Nobelist Dr. David Baltimore (for postdoctoral work for the first cloning/characterization of NF-κB p65/ RelA and the development of rapid retroviral production systems). He has published over 350 research articles and is the holder of 40 US patents and has been honored as one of the top 25 inventors at Stanford University.
Dr. Nolan is the first recipient of the Teal Innovator Award (2012) from the Department of Defense (a $3.3 million grant for advanced studies in ovarian cancer), the first recipient of an FDA BAAA, for “Bio-agent protection” grant, $3million, from the FDA for a “Cross-Species Immune System Reference”, and received the award for “Outstanding Research Achievement in 2011” from the Nature Publishing Group for his co-development of CyTOF applications in the immune system. Dr. Nolan has efforts in the study of Ebola, having developed instrument platforms to deploy in the field in Africa to study Ebola samples safely with the need to transport them to overseas labs (funded by a $3.5 million grant from the FDA) and another grant to study the effects of Zika and Ebola viruses on humans (also from the FDA). His current efforts have involved development of deep tissue profiling methods such as CODEX and MIBI that have contributed fundamentally to the Human Cell Atlas and cancer cell atlases being worked on worldwide.
Dr. Nolan is an outspoken proponent of translating public investment in basic research to serve the public welfare. Dr. Nolan was the founder of Rigel Inc. (NASDAQ: RIGL), and Nodality, Inc. (a diagnostics development company), BINA (a genomics computational infrastructure company sold to Roche Diagnostics), Founder of Apprise (sold to Roche Sequencing Solutions), co-Founder of Ionpath, co-Founder of Scale Bio, co-Founder of Akoya, and serves on the Boards of Directors of several companies as well as consults for other biotechnology companies. DVS Sciences, on which he was Chair of the Scientific Advisory Board, sold to Fluidigm for $207 million dollars (2014) on an investment of $14 million. Dr. Nolan is a member of the Parker Institute for Cancer Immunotherapy at Stanford.
Peter Skafish
Executive Director
Dr. Peter Skafish is a sociocultural anthropologist who works between his discipline and philosophy ...
Content cut off. Read original on https://old.reddit.com/r/UFOs/comments/1gvmdao/the_sol_foundation_and_their_new_white_paper_the/